Effects of Recombinant Human Erythropoietin (R-HuEPO) Treatment on Cardiovascular Hemodynamics in Hemodialysis Patients

Journal of Japanese Society for Dialysis Therapy
doi 10.4009/jsdt1985.22.733
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society for Dialysis Therapy

Related search

Changes in Hemodynamics and Plasma Vasoactive Endocrinological Factors With Long-Term Administration of Recombinant Human Erythropoietin in Anemic Patients Undergoing Chronic Hemodialysis.

Journal of Japanese Society for Dialysis Therapy
1993English

Study of Hemodialysis Patients Who Do Not Require Administration of Recombinant Human Erythropoietin.

Nihon Toseki Igakkai Zasshi
2000English

IL-7 Serum Levels and Lymphopenia in Hemodialysis Patients, Non-Responders to Recombinant Human Erythropoietin Therapy

Blood Cells, Molecules, and Diseases
Molecular MedicineHematologyMolecular BiologyCell Biology
2008English

A Trial of Blood Conservation in Cardiovascular Surgery. Effect of Recombinant Human Erythropoietin.

Japanese Journal of Cardiovascular Surgery
1990English

Anaemia and Its Response to Treatment With Recombinant Human Erythropoietin in Chronic Kidney Disease Patients

West African Journal of Medicine
2010English

Effectiveness of Erythropoietin in Hypertensive Hemodialysis Patients

Pharmacology and Clinical Pharmacy Research
2017English

Dose-Dependent Neurorestorative Effects of Delayed Treatment of Traumatic Brain Injury With Recombinant Human Erythropoietin in Rats

Journal of Neurosurgery
SurgeryNeurology
2011English

Recombinant Human Erythropoietin vs Transfusions in the Treatment of Anemia of Prematurity

Archives of Pediatrics & Adolescent Medicine
1994English

Recombinant Human Erythropoietin Α Modulates the Effects of Radiotherapy on Colorectal Cancer Microvessels

British Journal of Cancer
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy